Serial Number
87526825
Owner
Cansortium Holdings, LLCAttorney
Frank RobisonFirst Use Date
Nov 23, 2015
Filing Date
Jul 13, 2017
KNOX Trademark
Serial Number: 87526825 • Registration: 5614485
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Frank Robison ROBISON LAW LLC
2043 Buchanan Point
Lafayette, CO 80026
UNITED STATES
Trademark Details
Filing Date
July 13, 2017
Registration Date
November 27, 2018
First Use Anywhere
November 23, 2015
First Use in Commerce
December 9, 2016
Published for Opposition
September 11, 2018
Cancellation Date
June 6, 2025
Goods & Services
Pharmaceuticals and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; pharmaceutical preparations for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; none of the forgoing containing marijuana or extracts therefrom
Retail drug store and retail pharmaceutical dispensary store services that not do not feature goods containing marijuana or extracts thereform
Providing health information in the field of medical marijuana and regarding the indications and effects of particular cannabinoids; providing information pertaining to the benefits of the medicinal use of cannabis to treat certain ailments
Product research and development, not including marijuana or extracts therefrom
